While data-driven motion correction (DDMC) techniques have proven to enhance the visibility of lesions affected by motion, their impact on overall detectability remains unclear. This study investigates whether DDMC improves lesion detectability in PET-CT using FDG-18F. A moving platform simulated respiratory motion in a NEMA-IEC body phantom with varying amplitudes (0, 7, 10, 20, 30 mm) and target-to-background ratios (2, 5, 10.5). Scans were reconstructed with and without DDMC, and the spherical targets' maximal and mean recovery coefficient (RC) and contrast-to-noise ratio (CNR) were measured. DDMC results in higher RC values in the target spheres. CNR values increase for small, high-motion affected targets but decrease for larger spheres with smaller amplitudes. A sub-analysis shows that DDMC increases the contrast of the sphere along with a 36% increase in background noise. While DDMC significantly enhances contrast (RC), its impact on detectability (CNR) is less profound due to increased background noise. CNR improves for small targets with high motion amplitude, potentially enhancing the detectability of low-uptake lesions. Given that the increased background noise may reduce detectability for targets unaffected by motion, we suggest that DDMC reconstructions are used best in addition to non-DDMC reconstructions.

Diffusion-weighted imaging (DWI) has become a cornerstone of high-resolution rectal MRI, providing critical functional information that complements T2-weighted imaging (T2WI) throughout the management of rectal cancer. From baseline staging to restaging after neoadjuvant therapy and longitudinal surveillance during nonoperative management or post-surgical follow-up, DWI improves tumor detection, characterizes treatment response, and facilitates early identification of tumor regrowth or recurrence. This review offers a comprehensive overview of DWI in rectal cancer, emphasizing its technical characteristics, optimal acquisition strategies, and integration with qualitative and quantitative interpretive frameworks. The manuscript also addresses interpretive pitfalls, highlights emerging techniques such as intravoxel incoherent motion (IVIM), diffusion kurtosis imaging (DKI), and small field-of-view DWI, and explores the growing role of radiomics and artificial intelligence in advancing precision imaging. DWI, when rigorously implemented and interpreted, enhances the accuracy, reproducibility, and clinical utility of rectal MRI.

As non-surgical therapies gain acceptance in head and neck tumors, the importance of imaging has increased. New therapeutic methods (in radiation therapy, targeted biological therapy, immunotherapy) need better tumor characterization and prognostic information along with the accurate anatomy. Magnetic resonance imaging (MRI) has become the gold standard in head and neck cancer evaluation not only for staging but also for assessing tumor response, posttreatment status and complications, as well as for finding residual or recurrent tumor. Multiparametric anatomical and functional MRI (MP-MRI) is a true cancer imaging biomarker providing, in addition to high resolution tumor anatomy, more molecular and functional, qualitative and quantitative data using diffusion- weighted MRI (DW-MRI) and perfusion-dynamic contrast enhanced MRI (P-DCE-MRI), can improve the assessment of biological target volume and determine treatment response. DW-MRI provides information at the cellular level about the cell density and the integrity of the plasma membrane, based on water movement. P-DCE-MRI provides useful hemodynamic information about tissue vascularity and vascular permeability. Recent studies have shown promising results using radiomics features, MP-MRI has opened new perspectives in oncologic imaging with better realization of the latest technological advances with the help of artificial intelligence.

The rapid and accurate detection of COVID-19 (coronavirus disease 2019) from normal and pneumonia chest x-ray images is essential for timely diagnosis and treatment. The overlapping features in radiology images make it challenging for radiologists to distinguish COVID-19 cases. This research study investigates the effectiveness of combining local binary pattern (LBP) and histogram of oriented gradients (HOG) features with machine learning algorithms to differentiate COVID-19 from normal and pneumonia cases using chest x-rays. The proposed hybrid fusion model "RadientFusion-XR" utilizes LBP and HOG features with shallow learning algorithms. The proposed hybrid HOG-LBP fusion model, RadientFusion-XR, detects COVID-19 cases from normal and pneumonia classes. This fusion model provides a comprehensive representation, enabling more precise differentiation among the three classes. This methodology presents a promising and efficient tool for early COVID-19 and pneumonia diagnosis in clinical settings, with potential integration into automated diagnostic systems. The findings highlight the potential of this hybrid feature extraction and a shallow learning approach to improve diagnostic accuracy in chest x-ray analysis significantly. The hybrid model using LBP and HOG features with an ensemble model achieved an exceptional accuracy of 99% for binary class (COVID-19, normal) and 97% for multi-class (COVID-19, normal, pneumonia), respectively. These results demonstrate the efficacy of our hybrid approach in enhancing feature representation and achieving superior classification accuracy. The proposed RadientFusion-XR model with hybrid feature extraction and shallow learning approach significantly increases the accuracy of COVID-19 and pneumonia diagnoses from chest x-rays. The interpretable nature of RadientFusion-XR, alongside its effectiveness and explainability, makes it a valuable tool for clinical applications, fostering trust and enabling informed decision-making by healthcare professionals.

Accurate classification of pulmonary pure ground-glass nodules (pGGNs) is essential for distinguishing invasive adenocarcinoma (IVA) from adenocarcinoma in situ (AIS) and minimally invasive adenocarcinoma (MIA), which significantly influences treatment decisions. This study aims to develop a high-precision integrated strategy by combining radiomics-based feature extraction, Quantum Machine Learning (QML) models, and SHapley Additive exPlanations (SHAP) analysis to improve diagnostic accuracy and interpretability in pGGN classification. A total of 322 pGGNs from 275 patients were retrospectively analyzed. The CT images was randomly divided into training and testing cohorts (80:20), with radiomic features extracted from the training cohort. Three QML models-Quantum Support Vector Classifier (QSVC), Pegasos QSVC, and Quantum Neural Network (QNN)-were developed and compared with a classical Support Vector Machine (SVM). SHAP analysis was applied to interpret the contribution of radiomic features to the models' predictions. All three QML models outperformed the classical SVM, with the QNN model achieving the highest improvements ([Formula: see text]) in classification metrics, including accuracy (89.23%, 95% CI: 81.54% - 95.38%), sensitivity (96.55%, 95% CI: 89.66% - 100.00%), specificity (83.33%, 95% CI: 69.44% - 94.44%), and area under the curve (AUC) (0.937, 95% CI: 0.871 - 0.983), respectively. SHAP analysis identified Low Gray Level Run Emphasis (LGLRE), Gray Level Non-uniformity (GLN), and Size Zone Non-uniformity (SZN) as the most critical features influencing classification. This study demonstrates that the proposed integrated strategy, combining radiomics, QML models, and SHAP analysis, significantly enhances the accuracy and interpretability of pGGN classification, particularly in small-sample datasets. It offers a promising tool for early, non-invasive lung cancer diagnosis and helps clinicians make more informed treatment decisions. Not applicable.

Develop a fusion model based on explainable machine learning, combining multiparametric MRI subregional radiomics and deep learning, to preoperatively predict the lymphovascular invasion status in rectal cancer. We collected data from RC patients with histopathological confirmation from two medical centers, with 301 patients used as a training set and 75 patients as an external validation set. Using K-means clustering techniques, we meticulously divided the tumor areas into multiple subregions and extracted crucial radiomic features from them. Additionally, we employed an advanced Vision Transformer (ViT) deep learning model to extract features. These features were integrated to construct the SubViT model. To better understand the decision-making process of the model, we used the Shapley Additive Properties (SHAP) tool to evaluate the model's interpretability. Finally, we comprehensively assessed the performance of the SubViT model through receiver operating characteristic (ROC) curves, decision curve analysis (DCA), and the Delong test, comparing it with other models. In this study, the SubViT model demonstrated outstanding predictive performance in the training set, achieving an area under the curve (AUC) of 0.934 (95% confidence interval: 0.9074 to 0.9603). It also performed well in the external validation set, with an AUC of 0.884 (95% confidence interval: 0.8055 to 0.9616), outperforming both subregion radiomics and imaging-based models. Furthermore, decision curve analysis (DCA) indicated that the SubViT model provides higher clinical utility compared to other models. As an advanced composite model, the SubViT model demonstrated its efficiency in the non-invasive assessment of local vascular invasion (LVI) in rectal cancer.

Medical imaging sciences and diagnostic techniques for Breast Cancer (BC) imaging have advanced tremendously, particularly with the use of mammography images; however, radiologists may still misinterpret medical images of the breast, resulting in limitations and flaws in the screening process. As a result, Computer-Aided Design (CAD) systems have become increasingly popular due to their ability to operate independently of human analysis. Current CAD systems use grayscale analysis, which lacks the contrast needed to differentiate benign from malignant lesions. As part of this study, an innovative CAD system is presented that transforms standard grayscale mammography images into RGB colored through a three-path preprocessing framework developed for noise reduction, lesion highlighting, and tumor-centric intensity adjustment using a data-driven transfer function. In contrast to a generic approach, this approach statistically tailors colorization in order to emphasize malignant regions, thus enhancing the ability of both machines and humans to recognize cancerous areas. As a consequence of this conversion, breast tumors with anomalies become more visible, which allows us to extract more accurate features about them. In a subsequent step, Machine Learning (ML) algorithms are employed to classify these tumors as malign or benign cases. A pre-trained model is developed to extract comprehensive features from colored mammography images by employing this approach. A variety of techniques are implemented in the pre-processing section to minimize noise and improve image perception; however, the most challenging methodology is the application of creative techniques to adjust pixels' intensity values in mammography images using a data-driven transfer function derived from tumor intensity histograms. This adjustment serves to draw attention to tumors while reducing the brightness of other areas in the breast image. Measuring criteria such as accuracy, sensitivity, specificity, precision, F1-Score, and Area Under the Curve (AUC) are used to evaluate the efficacy of the employed methodologies. This work employed and tested a variety of pre-training and ML techniques. However, the combination of EfficientNetB0 pre-training with ML Support Vector Machines (SVM) produced optimal results with accuracy, sensitivity, specificity, precision, F1-Score, and AUC, of 99.4%, 98.7%, 99.1%, 99%, 98.8%, and 100%, respectively. It is clear from these results that the developed method does not only advance the state-of-the-art in technical terms, but also provides radiologists with a practical tool to aid in the reduction of diagnostic errors and increase the detection of early breast cancer.

Lung cancer remains the leading cause of cancer-related mortality worldwide, largely due to late-stage diagnosis. Early detection is critical for improving patient outcomes, yet current screening methods, such as low-dose computed tomography (CT), often lack the sensitivity and specificity required for early-stage detection. Here, we present a multimodal early screening platform that integrates a multiplexed laser-induced graphene (LIG) immunosensor with machine learning to enhance the accuracy of lung cancer diagnosis. Our platform enables the rapid, cost-effective, and simultaneous detection of four tumor markers─neuron-specific enolase (NSE), carcinoembryonic antigen (CEA), p53, and SOX2─with limits of detection (LOD) as low as 1.62 pg/mL. By combining proteomic data from the immunosensor with deep learning-based CT imaging features and clinical data, we developed a multimodal predictive model that achieves an area under the curve (AUC) of 0.936, significantly outperforming single-modality approaches. This platform offers a transformative solution for early lung cancer screening, particularly in resource-limited settings, and provides potential technical support for precision medicine in oncology.

Pneumonia detection in chest X-rays (CXR) increasingly relies on AI-driven diagnostic systems. However, their "black-box" nature often lacks transparency, underscoring the need for interpretability to improve patient outcomes. This study presents the first application of the Deformable Prototypical Part Network (D-ProtoPNet), an ante-hoc interpretable deep learning (DL) model, for pneumonia classification in pediatric patients' CXR images. Clinical insights were integrated through expert radiologist evaluation of the model's learned prototypes and activated image patches, ensuring that explanations aligned with medically meaningful features. The model was developed and tested on a retrospective dataset of 5,856 CXR images of pediatric patients, ages 1-5 years. The images were originally acquired at a tertiary academic medical center as part of routine clinical care and were publicly hosted on a Kaggle platform. This dataset comprised anterior-posterior images labeled normal, viral, and bacterial. It was divided into 80 % training and 20 % validation splits, and utilised in a supervised five-fold cross-validation. Performance metrics were compared with the original ProtoPNet, utilising ResNet50 as the base model. An experienced radiologist assessed the clinical relevance of the learned prototypes, patch activations, and model explanations. The D-ProtoPNet achieved an accuracy of 86 %, precision of 86 %, recall of 85 %, and AUC of 93 %, marking a 3 % improvement over the original ProtoPNet. While further optimisation is required before clinical use, the radiologist praised D-ProtoPNet's intuitive explanations, highlighting its interpretability and potential to aid clinical decision-making. Prototypical part learning offers a balance between classification performance and explanation quality, but requires improvements to match the accuracy of black-box models. This study underscores the importance of integrating domain expertise during model evaluation to ensure the interpretability of XAI models is grounded in clinically valid insights.

Predicting distant metastases in soft tissue sarcomas (STS) is vital for guiding clinical decision-making. Recent advancements in radiomics and deep learning (DL) models have shown promise, but their diagnostic accuracy remains unclear. This meta-analysis aims to assess the performance of radiomics and DL-based models in predicting metastases in STS by analyzing pooled sensitivity and specificity. Following PRISMA guidelines, a thorough search was conducted in PubMed, Web of Science, and Embase. A random-effects model was used to estimate the pooled area under the curve (AUC), sensitivity, and specificity. Subgroup analyses were performed based on imaging modality (MRI, PET, PET/CT), feature extraction method (DL radiomics [DLR] vs. handcrafted radiomics [HCR]), incorporation of clinical features, and dataset used. Heterogeneity by I² statistic, leave-one-out sensitivity analyses, and publication bias by Egger's test assessed model robustness and potential biases. Ninetheen studies involving 1712 patients were included. The pooled AUC for predicting metastasis was 0.88 (95% CI: 0.80-0.92). The pooled AUC values were 88% (95% CI: 77-89%) for MRI-based models, 80% (95% CI: 76-92%) for PET-based models, and 91% (95% CI: 78-93%) for PET/CT-based models, with no significant differences (p = 0.75). DL-based models showed significantly higher sensitivity than HCR models (p < 0.01). Including clinical features did not significantly improve model performance (AUC: 0.90 vs. 0.88, p = 0.99). Significant heterogeneity was noted (I² > 25%), and Egger's test suggested potential publication bias (p < 0.001). Radiomics models showed promising potential for predicting metastases in STSs, with DL approaches outperforming traditional HCR. While integrating this approach into routine clinical practice is still evolving, it can aid physicians in identifying high-risk patients and implementing targeted monitoring strategies to reduce the risk of severe complications associated with metastasis. However, challenges such as heterogeneity, limited external validation, and potential publication bias persist. Future research should concentrate on standardizing imaging protocols and conducting multi-center validation studies to improve the clinical applicability of radiomics predictive models.